About
KU Leuven is the highest‑ranked university in Horizon Europe and a leading centre for interdisciplinary research.
Prof. Steven Simoens’ unit in the Department of Pharmaceutical and Pharmacological Sciences specialises in health economics, market access, pricing and brodader pharmaceutical policy. Proven track record of experience and expertise in orphan and personalized medicines, cell-gene therapy, advanced therapies and vaccines.
We actively seek partners to join their forming consortia in healthcare, pharmaceuticals, vaccines, medical devices and personalised interventions across Horizon Europe calls.
Mission: Cancer
HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer ResearchHORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of diseaseHORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancersHORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative careHORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for UkraineHORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients